PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1799581
PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1799581
Global HPV Testing and Pap Test Market Size Study & Forecast, by Test Type (HPV Testing and Pap Test) and End User (Laboratories, Hospitals, Physician's Offices & Clinics) and Regional Forecasts 2022-2032
The Global HPV Testing and Pap Test Market is valued approximately at USD 6.28 billion in 2024 and is anticipated to expand at a robust CAGR of 13.20% over the forecast period 2025-2035. HPV testing and Pap tests serve as critical diagnostic tools in the detection and prevention of cervical cancer, enabling timely intervention and improving patient outcomes. HPV testing encompasses Follow-Up HPV Testing, Co-Testing, and Primary HPV Testing, while Pap tests remain a cornerstone of routine cervical screening. The market growth is being propelled by rising awareness of cervical health, increasing prevalence of HPV infections, and substantial investments in diagnostic infrastructure across hospitals, laboratories, and clinics globally. Moreover, the adoption of advanced molecular diagnostic technologies further stimulates the market, offering enhanced sensitivity and accuracy in early detection protocols.
The surging incidence of cervical cancer worldwide has reinforced the indispensable role of HPV testing and Pap tests in preventive healthcare. According to the World Health Organization, cervical cancer remains the fourth most common cancer among women globally, with an estimated 604,000 new cases in 2020. The integration of HPV testing alongside traditional cytology improves diagnostic accuracy, drives early intervention, and enhances patient monitoring. Rising government initiatives promoting cervical cancer screening, coupled with technological innovations such as automated cytology and high-throughput molecular assays, are providing lucrative avenues for market expansion. Nonetheless, challenges including limited access to diagnostic facilities in underdeveloped regions and the growing emphasis on vaccination over screening may modulate growth rates over the forecast period.
Regional dynamics depict North America as the dominant market in 2025, driven by the presence of advanced healthcare infrastructure, extensive screening programs, and widespread adoption of molecular diagnostic solutions. Europe follows closely, fueled by rising healthcare expenditure and proactive national cancer screening initiatives across countries like Germany, the UK, and France. The Asia Pacific region is projected to witness the fastest growth during 2025-2035, propelled by expanding healthcare access, increasing public awareness regarding cervical cancer, and supportive governmental policies in nations such as China, India, and Japan. Latin America and the Middle East & Africa are also expected to register steady growth, with emerging healthcare networks and ongoing investments in diagnostic laboratories providing a positive outlook for market stakeholders.
Major market players included in this report are:
- Roche Diagnostics
- Abbott Laboratories
- Hologic, Inc.
- Becton, Dickinson and Company
- Qiagen N.V.
- Siemens Healthineers
- PerkinElmer, Inc.
- BD Life Sciences
- Bio-Rad Laboratories, Inc.
- Danaher Corporation
- Fujirebio Inc.
- Cepheid Inc.
- Myriad Genetics, Inc.
- Genomica S.A.U.
- LabCorp
Global HPV Testing and Pap Test Market Report Scope:
- Historical Data - 2023, 2024
- Base Year for Estimation - 2024
- Forecast period - 2025-2035
- Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
- Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
- Customization Scope - Free report customization (equivalent up to 8 analysts' working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study. The report also provides detailed information about crucial aspects, such as driving factors and challenges, which will define the future growth of the market. Additionally, it incorporates potential opportunities in micro-markets for stakeholders to invest, along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segments of the market are explained below:
By Test Type:
- HPV Testing (Follow-Up HPV Testing, Co-Testing, Primary HPV Testing)
- Pap Test
By End User:
- Laboratories
- Hospitals
- Physician's Offices & Clinics
By Region:
- North America
- U.S.
- Canada
- Europe
- UK
- Germany
- France
- Spain
- Italy
- RoE
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- RoAPAC
- Latin America
- Brazil
- Mexico
- Middle East & Africa
- UAE
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
Key Takeaways:
- Market Estimates & Forecast for 10 years from 2025 to 2035.
- Annualized revenues and regional level analysis for each market segment.
- Detailed analysis of geographical landscape with Country level analysis of major regions.
- Competitive landscape with information on major players in the market.
- Analysis of key business strategies and recommendations on future market approach.
- Analysis of competitive structure of the market.
- Demand side and supply side analysis of the market.
Table of Contents
Chapter 1. Global HPV Testing and Pap Test Market Report Scope & Methodology
- 1.1. Research Objective
- 1.2. Research Methodology
- 1.2.1. Forecast Model
- 1.2.2. Desk Research
- 1.2.3. Top Down and Bottom-Up Approach
- 1.3. Research Attributes
- 1.4. Scope of the Study
- 1.4.1. Market Definition
- 1.4.2. Market Segmentation
- 1.5. Research Assumption
- 1.5.1. Inclusion & Exclusion
- 1.5.2. Limitations
- 1.5.3. Years Considered for the Study
Chapter 2. Executive Summary
- 2.1. CEO/CXO Standpoint
- 2.2. Strategic Insights
- 2.3. ESG Analysis
- 2.4. Key Findings
Chapter 3. Global HPV Testing and Pap Test Market Forces Analysis
- 3.1. Market Forces Shaping The Global HPV Testing and Pap Test Market (2024-2035)
- 3.2. Drivers
- 3.2.1. Rising prevalence of HPV infections and increased cervical cancer screening initiatives
- 3.2.2. Technological advancements in molecular diagnostics and automated cytology
- 3.2.3. Government-funded national screening programs and reimbursement support
- 3.3. Restraints
- 3.3.1. Limited access to diagnostic facilities and infrastructure in low-income regions
- 3.3.2. Shifts in preventive strategy toward vaccination potentially affecting screening uptake
- 3.3.3. Stringent regulatory pathways and high cost of advanced assays
- 3.4. Opportunities
- 3.4.1. Expansion of high-throughput HPV testing and point-of-care solutions in emerging markets
- 3.4.2. Integration of HPV assays with digital pathology and AI-enabled cytology workflows
- 3.4.3. Public-private partnerships to scale screening programs and lab networks
- 3.4.4. Adjunct revenue opportunities from reflex testing, genotyping and longitudinal patient monitoring
Chapter 4. Global HPV Testing and Pap Test Industry Analysis
- 4.1. Porter's 5 Forces Model
- 4.1.1. Bargaining Power of Buyer
- 4.1.2. Bargaining Power of Supplier
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.2. Porter's 5 Force Forecast Model (2024-2035)
- 4.3. PESTEL Analysis
- 4.3.1. Political
- 4.3.2. Economical
- 4.3.3. Social
- 4.3.4. Technological
- 4.3.5. Environmental
- 4.3.6. Legal
- 4.4. Top Investment Opportunities
- 4.5. Top Winning Strategies (2025)
- 4.6. Market Share Analysis (2024-2025)
- 4.7. Global Pricing Analysis And Trends 2025
- 4.8. Analyst Recommendation & Conclusion
Chapter 5. Global HPV Testing and Pap Test Market Size & Forecasts by Test Type 2025-2035
- 5.1. Market Overview
- 5.2. Global HPV Testing and Pap Test Market Performance - Potential Analysis (2025)
- 5.3. HPV Testing (Follow-Up HPV Testing)
- 5.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.3.2. Market size analysis, by region, 2025-2035
- 5.4. HPV Testing (Co-Testing)
- 5.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.4.2. Market size analysis, by region, 2025-2035
- 5.5. HPV Testing (Primary HPV Testing)
- 5.5.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.5.2. Market size analysis, by region, 2025-2035
- 5.6. Pap Test
- 5.6.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 5.6.2. Market size analysis, by region, 2025-2035
Chapter 6. Global HPV Testing and Pap Test Market Size & Forecasts by End User 2025-2035
- 6.1. Market Overview
- 6.2. Global HPV Testing and Pap Test Market Performance - Potential Analysis (2025)
- 6.3. Laboratories
- 6.3.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 6.3.2. Market size analysis, by region, 2025-2035
- 6.4. Hospitals
- 6.4.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 6.4.2. Market size analysis, by region, 2025-2035
- 6.5. Physician's Offices & Clinics
- 6.5.1. Top Countries Breakdown Estimates & Forecasts, 2024-2035
- 6.5.2. Market size analysis, by region, 2025-2035
Chapter 7. Global HPV Testing and Pap Test Market Size & Forecasts by Region 2025-2035
- 7.1. HPV Testing and Pap Test Market, Regional Market Snapshot
- 7.2. Top Leading & Emerging Countries
- 7.3. North America HPV Testing and Pap Test Market
- 7.3.1. U.S. HPV Testing and Pap Test Market
- 7.3.1.1. Test type breakdown size & forecasts, 2025-2035
- 7.3.1.2. End user breakdown size & forecasts, 2025-2035
- 7.3.2. Canada HPV Testing and Pap Test Market
- 7.3.2.1. Test type breakdown size & forecasts, 2025-2035
- 7.3.2.2. End user breakdown size & forecasts, 2025-2035
- 7.3.1. U.S. HPV Testing and Pap Test Market
- 7.4. Europe HPV Testing and Pap Test Market
- 7.4.1. UK HPV Testing and Pap Test Market
- 7.4.1.1. Test type breakdown size & forecasts, 2025-2035
- 7.4.1.2. End user breakdown size & forecasts, 2025-2035
- 7.4.2. Germany HPV Testing and Pap Test Market
- 7.4.2.1. Test type breakdown size & forecasts, 2025-2035
- 7.4.2.2. End user breakdown size & forecasts, 2025-2035
- 7.4.3. France HPV Testing and Pap Test Market
- 7.4.3.1. Test type breakdown size & forecasts, 2025-2035
- 7.4.3.2. End user breakdown size & forecasts, 2025-2035
- 7.4.4. Spain HPV Testing and Pap Test Market
- 7.4.4.1. Test type breakdown size & forecasts, 2025-2035
- 7.4.4.2. End user breakdown size & forecasts, 2025-2035
- 7.4.5. Italy HPV Testing and Pap Test Market
- 7.4.5.1. Test type breakdown size & forecasts, 2025-2035
- 7.4.5.2. End user breakdown size & forecasts, 2025-2035
- 7.4.6. Rest of Europe HPV Testing and Pap Test Market
- 7.4.6.1. Test type breakdown size & forecasts, 2025-2035
- 7.4.6.2. End user breakdown size & forecasts, 2025-2035
- 7.4.1. UK HPV Testing and Pap Test Market
- 7.5. Asia Pacific HPV Testing and Pap Test Market
- 7.5.1. China HPV Testing and Pap Test Market
- 7.5.1.1. Test type breakdown size & forecasts, 2025-2035
- 7.5.1.2. End user breakdown size & forecasts, 2025-2035
- 7.5.2. India HPV Testing and Pap Test Market
- 7.5.2.1. Test type breakdown size & forecasts, 2025-2035
- 7.5.2.2. End user breakdown size & forecasts, 2025-2035
- 7.5.3. Japan HPV Testing and Pap Test Market
- 7.5.3.1. Test type breakdown size & forecasts, 2025-2035
- 7.5.3.2. End user breakdown size & forecasts, 2025-2035
- 7.5.4. Australia HPV Testing and Pap Test Market
- 7.5.4.1. Test type breakdown size & forecasts, 2025-2035
- 7.5.4.2. End user breakdown size & forecasts, 2025-2035
- 7.5.5. South Korea HPV Testing and Pap Test Market
- 7.5.5.1. Test type breakdown size & forecasts, 2025-2035
- 7.5.5.2. End user breakdown size & forecasts, 2025-2035
- 7.5.6. Rest of APAC HPV Testing and Pap Test Market
- 7.5.6.1. Test type breakdown size & forecasts, 2025-2035
- 7.5.6.2. End user breakdown size & forecasts, 2025-2035
- 7.5.1. China HPV Testing and Pap Test Market
- 7.6. Latin America HPV Testing and Pap Test Market
- 7.6.1. Brazil HPV Testing and Pap Test Market
- 7.6.1.1. Test type breakdown size & forecasts, 2025-2035
- 7.6.1.2. End user breakdown size & forecasts, 2025-2035
- 7.6.2. Mexico HPV Testing and Pap Test Market
- 7.6.2.1. Test type breakdown size & forecasts, 2025-2035
- 7.6.2.2. End user breakdown size & forecasts, 2025-2035
- 7.6.1. Brazil HPV Testing and Pap Test Market
- 7.7. Middle East and Africa HPV Testing and Pap Test Market
- 7.7.1. UAE HPV Testing and Pap Test Market
- 7.7.1.1. Test type breakdown size & forecasts, 2025-2035
- 7.7.1.2. End user breakdown size & forecasts, 2025-2035
- 7.7.2. Saudi Arabia (KSA) HPV Testing and Pap Test Market
- 7.7.2.1. Test type breakdown size & forecasts, 2025-2035
- 7.7.2.2. End user breakdown size & forecasts, 2025-2035
- 7.7.3. South Africa HPV Testing and Pap Test Market
- 7.7.3.1. Test type breakdown size & forecasts, 2025-2035
- 7.7.3.2. End user breakdown size & forecasts, 2025-2035
- 7.7.1. UAE HPV Testing and Pap Test Market
Chapter 8. Competitive Intelligence
- 8.1. Top Market Strategies
- 8.2. Roche Diagnostics
- 8.2.1. Company Overview
- 8.2.2. Key Executives
- 8.2.3. Company Snapshot
- 8.2.4. Financial Performance (Subject to Data Availability)
- 8.2.5. Product/Services Port
- 8.2.6. Recent Development
- 8.2.7. Market Strategies
- 8.2.8. SWOT Analysis
- 8.3. Abbott Laboratories
- 8.4. Hologic, Inc.
- 8.5. Becton, Dickinson and Company
- 8.6. Qiagen N.V.
- 8.7. Siemens Healthineers
- 8.8. PerkinElmer, Inc.
- 8.9. BD Life Sciences
- 8.10. Bio-Rad Laboratories, Inc.
- 8.11. Danaher Corporation
- 8.12. Fujirebio Inc.
- 8.13. Cepheid Inc.
- 8.14. Myriad Genetics, Inc.
- 8.15. Genomica S.A.U.
- 8.16. LabCorp
